Glucagon (rDNA origin, Novo Nordisk)
胰高血糖素（诺和诺德）
Report date: 2026/01/23 09:55:45
Base Information
Drug NameGlucagon (rDNA origin, Novo Nordisk)
Drug Alias Name +[11]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date1996/05/01
Country/Territory +[4]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A
Develop Information
Active CompaniesNovo Nordisk A/S
Inactive CompaniesTechnical University Of DenmarkCharite University, Berlin, Germany
Active Indications
Inactive Indications